Botulinum Toxin Type A
Jeuveau is a prescription botulinum toxin type A injection used to temporarily improve the appearance of moderate to severe glabellar lines (frown lines) in adults. As a neuromodulator, it works by blocking nerve signals to specific muscles, causing temporary relaxation that reduces the appearance of lines and wrinkles. This cosmetic treatment is administered by healthcare professionals and is designed for patients seeking a non-surgical option to address facial wrinkles.
Jeuveau is an injectable cosmetic treatment that temporarily relaxes facial muscles to reduce the appearance of frown lines between the eyebrows.
Key facts at a glance
- RxNorm
- 2117872
- Generic
- Jeuveau
- Class
- brand-name
- Brands
- —
- Availability
- rx
- Lactation
- unknown
- Routes
- —
- Forms
- —
- Regions
- US, EU, CN, JP
- Monitoring
- —
This page is for informational purposes only.
Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.
Jeuveau is FDA-approved for the temporary improvement in the appearance of moderate to severe glabellar lines (vertical frown lines between the eyebrows) in adult patients. It is used purely for cosmetic purposes to create a smoother, more relaxed facial appearance.
Jeuveau contains prabotulinumtoxinA-xvfs, a botulinum toxin type A neurotoxin. It works by blocking the release of acetylcholine, a neurotransmitter that signals muscles to contract. This causes temporary muscle relaxation in the treated area, which helps smooth out existing lines and may prevent the deepening of wrinkles caused by repeated facial expressions.
Jeuveau should only be administered by qualified healthcare professionals. Common side effects may include headache, eyelid drooping, or injection site reactions. It is contraindicated in patients with known allergies to botulinum toxin products or active infections at the injection site. Effects typically last 3-4 months, and patients should disclose their full medical history and current medications to their provider before treatment.
Official drug label
WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed July 26, 2026. · Read our editorial policy